Ambulatory Cancer Pain Management: A Feasibility Study

Sponsor
M.D. Anderson Cancer Center (Other)
Overall Status
Completed
CT.gov ID
NCT00507351
Collaborator
(none)
30
4
36
7.5
0.2

Study Details

Study Description

Brief Summary

The primary purpose of this study is to examine the feasibility of collecting pain and other symptom data in outpatient treatment centers across multiple institutions in the Texas Medical Center (TMC). We will also examine the prevalence and severity of cancer-related pain and begin to identify other commonly reported symptoms in outpatient settings. Factors that interfere with management of pain will also be examined. Additionally, the study will explore patient satisfaction with pain management and pain education in outpatient settings. The specific aims of this study include:

Primary Objective:

-Explore the feasibility of a collaborative effort by oncology nurses to collect pain and symptom data across multiple institutions that care for ambulatory cancer patients in the TMC.

Secondary Objectives:
  • Describe the prevalence and severity of pain and other symptoms in persons with breast, colorectal, lung, or prostate cancer who are receiving chemotherapy in the outpatient setting.

  • Describe factors that interfere with adequate pain management in these patients.

  • Examine patient satisfaction with pain management and patient education about pain management.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Questionnaire

Detailed Description

You will be asked to complete 3 questionnaires that will take a total of about 20 minutes to complete. Your name or medical record number will not appear on the questionnaires. You will be assigned a study subject code number. The study chair will keep a file that links your name to the code.

The first questionnaire will ask for basic demographic information (such as gender, ethnicity, and education) and your current chemotherapy and pain medications. If you cannot remember the names of these medications, researchers will locate them in your M. D. Anderson medical record.

The second questionnaire asks you to rate your pain and a variety of symptoms (for example, fatigue and nausea).

The last questionnaire includes 3 sections. The first section asks about your beliefs about pain and its treatment. The second part asks for your opinion about your pain management and about the education you have received about pain management. On the last page, you will be asked to use a picture of the outline of a body to show the researchers where you have pain.

Once you have completed these questionnaires, you will be considered off-study.

This is an investigational study. Up to 125 patients will take part in this study. Up to 35 will be enrolled at M. D. Anderson.

Study Design

Study Type:
Observational
Actual Enrollment :
30 participants
Observational Model:
Case-Only
Time Perspective:
Prospective
Official Title:
Ambulatory Cancer Pain Management: A Feasibility Study
Study Start Date :
Jul 1, 2006
Actual Primary Completion Date :
Jul 1, 2009
Actual Study Completion Date :
Jul 1, 2009

Arms and Interventions

Arm Intervention/Treatment
Cancer Pain Management

Patients receiving chemotherapy for breast, colon, lung, or prostate cancer.

Behavioral: Questionnaire
3 questionnaires that will take 20 minutes total to complete.
Other Names:
  • Survey
  • Outcome Measures

    Primary Outcome Measures

    1. Pain and symptom data across multiple institutions [Survey data collection taking 30 minutes, collecation accomplished at multiple sites over 3 years]

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years and Older
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    1. Diagnosis of breast, colorectal, lung, or prostate cancer (any histological type).

    2. Currently undergoing chemotherapy.

    3. Age 18 or older.

    4. Able to read, write, and speak English.

    5. Able to understand the purpose of this study.

    6. Must be a patient at one of the four participating institutions.

    7. Must be receiving the 2nd, 3rd, or 4th cycle of chemotherapy.

    Exclusion Criteria:
    1. Receiving chemotherapy in preparation for a bone marrow or stem cell transplant

    2. Received a bone marrow or stem cell transplant

    3. Age 17 or younger

    4. Receiving weekly chemotherapy.

    5. Receiving hormonal therapy alone.

    6. Receiving radiation or chemoradiation.

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Memorial Hermann Hospital Houston Texas United States 77030
    2 Methodist Hospital Houston Texas United States 77030
    3 Michael E. DeBakey Veterans Administration Medical Center Houston Texas United States 77030
    4 U.T.M.D. Anderson Cancer Center Houston Texas United States 77030

    Sponsors and Collaborators

    • M.D. Anderson Cancer Center

    Investigators

    • Principal Investigator: Anita Broxson, RN, M.D. Anderson Cancer Center

    Study Documents (Full-Text)

    None provided.

    More Information

    Additional Information:

    Publications

    None provided.
    Responsible Party:
    M.D. Anderson Cancer Center
    ClinicalTrials.gov Identifier:
    NCT00507351
    Other Study ID Numbers:
    • 2005-0841
    First Posted:
    Jul 26, 2007
    Last Update Posted:
    Aug 1, 2012
    Last Verified:
    Jul 1, 2012

    Study Results

    No Results Posted as of Aug 1, 2012